000 | 01902 a2200529 4500 | ||
---|---|---|---|
005 | 20250513222453.0 | ||
264 | 0 | _c20010105 | |
008 | 200101s 0 0 eng d | ||
022 | _a1074-5521 | ||
024 | 7 |
_a10.1016/s1074-5521(00)00023-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWoo, L L | |
245 | 0 | 0 |
_aPotent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates. _h[electronic resource] |
260 |
_bChemistry & biology _cOct 2000 |
||
300 |
_a773-91 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAlanine _xanalogs & derivatives |
650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
650 | 0 | 4 |
_aArylsulfatases _xantagonists & inhibitors |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCoumarins _xchemical synthesis |
650 | 0 | 4 |
_aDehydroepiandrosterone Sulfate _xmetabolism |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEstrone _xanalogs & derivatives |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlycine _xanalogs & derivatives |
650 | 0 | 4 |
_aHeterocyclic Compounds, 3-Ring _xchemical synthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrogen Bonding |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aMicrosomes _xdrug effects |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 |
_aPlacenta _xdrug effects |
650 | 0 | 4 |
_aPostmenopause _xmetabolism |
650 | 0 | 4 | _aSteryl-Sulfatase |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aSulfatases _xantagonists & inhibitors |
650 | 0 | 4 |
_aSulfonamides _xchemical synthesis |
650 | 0 | 4 | _aSulfonic Acids |
700 | 1 | _aPurohit, A | |
700 | 1 | _aMalini, B | |
700 | 1 | _aReed, M J | |
700 | 1 | _aPotter, B V | |
773 | 0 |
_tChemistry & biology _gvol. 7 _gno. 10 _gp. 773-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1074-5521(00)00023-5 _zAvailable from publisher's website |
999 |
_c10978176 _d10978176 |